{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T07:27:48Z","timestamp":1785914868290,"version":"3.56.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.euo.2026.04.013","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:23:30Z","timestamp":1779135810000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysis"],"prefix":"10.1016","author":[{"given":"Donato","family":"Cannoletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Di Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Pecoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Salfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Tellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Barletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Vogl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Dell\u2019Oglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Stabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gandaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Breda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Gillessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Paone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Gallina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.04.013_b0005","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.eururo.2025.03.003","article-title":"A comprehensive systematic review and meta-analysis of the role of prostate-specific membrane antigen positron emission tomography for prostate cancer diagnosis and primary staging before definitive treatment","volume":"87","author":"Mazzone","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.013_b0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate Cancer-2024 update. Part I: Screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.013_b0015","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(20)30314-7","article-title":"Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study","volume":"395","author":"Hofman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.euo.2026.04.013_b0020","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.euf.2019.05.005","article-title":"Can Ga-68 PSMA PET\/CT replace conventional imaging modalities for primary lymph node and bone staging of prostate cancer?","volume":"6","author":"Esen","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2026.04.013_b0025","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1007\/s00259-023-06355-5","article-title":"Total-body [68 Ga]Ga-PSMA-11 PET\/CT improves detection rate compared with conventional [68 Ga]Ga-PSMA-11 PET\/CT in patients with biochemical recurrent prostate cancer","volume":"50","author":"Wang","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2026.04.013_b0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.eururo.2025.05.006","volume":"88","author":"Mazzone","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.013_b0035","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijrobp.2006.04.029","article-title":"Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference","volume":"65","author":"Roach","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.euo.2026.04.013_b0040","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.euo.2018.04.014","article-title":"Impact of biochemical failure after salvage radiation therapy on prostate cancer-specific mortality: competition between age and time to biochemical failure","volume":"1","author":"Jackson","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.04.013_b0045","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.eururo.2019.01.049","volume":"77","author":"Perera","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.013_b0050","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/MOU.0000000000001312","article-title":"Treatment of biochemical recurrence after primary therapy with curative intent","volume":"35","author":"Roessler","year":"2025","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.euo.2026.04.013_b0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s11547-018-0890-7","article-title":"Could 68-Ga PSMA PET\/CT become a new tool in the decision-making strategy of prostate cancer patients with biochemical recurrence of PSA after radical prostatectomy? A preliminary, monocentric series","volume":"123","author":"De Bari","year":"2018","journal-title":"Radiol Med"},{"key":"10.1016\/j.euo.2026.04.013_b0060","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2026.04.013_b0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami","year":"2020","journal-title":"Emerg Med J"},{"key":"10.1016\/j.euo.2026.04.013_b0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.euo.2026.04.013_b0075","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.eururo.2025.07.021","article-title":"Guidelines for meta-analyses and systematic reviews in urology","volume":"88","author":"Vickers","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.013_b0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2026.04.013_b0085","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/pros.23347","article-title":"68 Ga-PSMA-PET for radiation treatment planning in prostate cancer recurrences after surgery: individualized medicine or new standard in salvage treatment","volume":"77","author":"Habl","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.euo.2026.04.013_b0090","doi-asserted-by":"crossref","unstructured":"Kranzb\u00fchler B, M\u00fcller J, Becker AS, et al. Detection rate and localization of prostate cancer recurrence using 68Ga-PSMA-11 PET\/MRI in patients with Low PSA Values \u2264 .5 ng\/mL. J Nucl Med 2020;61:194\u2013201.","DOI":"10.2967\/jnumed.118.225276"},{"key":"10.1016\/j.euo.2026.04.013_b0095","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.radonc.2017.10.022","article-title":"Delineating sites of failure following post-prostatectomy radiation treatment using 68Ga-PSMA-PET","volume":"126","author":"Byrne","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.euo.2026.04.013_b0100","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.52971","article-title":"PSMA-PET\/CT findings in patients with high-risk biochemically recurrent prostate cancer with no metastatic disease by conventional imaging","volume":"8","author":"Holzgreve","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2026.04.013_b0105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/RLU.0000000000002169","article-title":"68Ga-PSMA PET\/CT in patients with biochemical recurrence of prostate cancer: a prospective, 2-center study","volume":"43","author":"Zacho","year":"2018","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.euo.2026.04.013_b0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13014-020-01733-x","article-title":"Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techniques","volume":"16","author":"Rowe","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.euo.2026.04.013_b0115","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2967\/jnumed.121.262412","article-title":"A comprehensive assessment of 68Ga-PSMA-11 PET in biochemically recurrent prostate cancer: results from a prospective multicenter study on 2,005 patients","volume":"63","author":"Abghari-Gerst","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2026.04.013_b0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.urology.2022.08.035","article-title":"Failure patterns by PSMA PET for recurrent prostate cancer after prostatectomy and salvage radiation","volume":"170","author":"Imber","year":"2022","journal-title":"Urology"},{"key":"10.1016\/j.euo.2026.04.013_b0125","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","article-title":"Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: A prospective single-arm clinical trial","volume":"5","author":"Fendler","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.euo.2026.04.013_b0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.eururo.2023.03.001","volume":"84","author":"Chow","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2026.04.013_b0135","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s00259-021-05189-3","article-title":"Performance of [68Ga]Ga-PSMA-11 PET\/CT in patients with recurrent prostate cancer after prostatectomy-a multi-centre evaluation of 2533 patients","volume":"48","author":"Afshar-Oromieh","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.euo.2026.04.013_b0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2967\/jnumed.115.154153","article-title":"Evaluation of hybrid 68Ga-PSMA ligand PET\/CT in 248 patients with biochemical recurrence after radical prostatectomy","volume":"56","author":"Eiber","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1016\/j.euo.2026.04.013_b0145","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00345-020-03220-0","article-title":"Site-specific relapse patterns of patients with biochemical recurrence following radical prostatectomy assessed by 68Ga-PSMA-11 PET\/CT or 11C-Choline PET\/CT: impact of postoperative treatments","volume":"39","author":"Devos","year":"2021","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2026.04.013_b0150","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S1470-2045(25)00197-4","article-title":"Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial","volume":"26","author":"Ost","year":"2025","journal-title":"Lancet Oncol"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126001215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126001215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T20:23:35Z","timestamp":1779135815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126001215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"alternative-id":["S2588931126001215"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.04.013","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Diagnostic Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Patients with Rising PSA After Radical Prostatectomy and Postoperative Radiotherapy: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}